Back
Graham Vs. Novo Nordisk AS Industry Stock Comparison
Buy
57
GHM
Graham
Last Price:
$43.16
Seasonality Move:
10.75%
Sell
25
NVO
Novo Nordisk AS
Last Price:
$85.63
Seasonality Move:
6.68%
Sell
25
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NVO] share price is $85.64. The Score for NVO is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GHM Stock Price Chart
NVO Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $85.64The current trend is relatively stagnant and NVO is experiencing buying pressure, which is a positive indicator for future bullish movement.
GHM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.85 | Buy |
Relative Strength Index (14 RSI): | 49.81 | Sell |
Chaikin Money Flow: | 18859 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (42.31 - 45.51) | Sell |
Bollinger Bands (100): | (28.64 - 42.18) | Buy |
NVO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.06 | Sell |
Relative Strength Index (14 RSI): | 31.71 | Sell |
Chaikin Money Flow: | 6521757 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (86.72 - 109.1) | Sell |
Bollinger Bands (100): | (99.51 - 129.55) | Sell |
GHM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 44.7 | Sell |
20-day SMA: | 43.92 | Sell |
50-day SMA: | 40.88 | Buy |
200-day SMA: | 32.22 | Buy |
8-day EMA: | 44.28 | Sell |
20-day EMA: | 43.79 | Sell |
50-day EMA: | 41.03 | Buy |
200-day EMA: | 32.72 | Buy |
NVO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 86.04 | Sell |
20-day SMA: | 94.95 | Sell |
50-day SMA: | 102.54 | Sell |
200-day SMA: | 123.74 | Sell |
8-day EMA: | 86.81 | Sell |
20-day EMA: | 92.64 | Sell |
50-day EMA: | 101.62 | Sell |
200-day EMA: | 114.8 | Sell |
Graham Earnings Growth & GHM Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.41 per share.
Novo Nordisk AS Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.75 per share, and an increase next year of $0.54 per share.
Graham Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |